The round was led by FCA Venture Partners, with strong participation from existing investors including SpringTide, which led the company's previous funding round, and Oncology Ventures. The investment will accelerate IgniteData's growth as it scales its global research site network and advances its flagship product, IgniteData Archer - a platform that enables seamless transfer of clinical trial data from electronic health records (EHR) to electronic data capture (EDC) systems and data warehouses.

IgniteData is on a mission to revolutionize clinical trials through intelligent automation. By enabling real-time, secure transfer of clinical data between healthcare providers and life science companies, IgniteData accelerates research while reducing burden on clinical sites. With deployments across premier research centers and partnerships with top pharmaceutical sponsors, IgniteData is redefining what's possible in clinical trial operations.